Sepehr Jamalkhani

Iran University of Medical Sciences — IR

Medicine · Health Sciences

8h-index1.1kcitations17works14.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(7), Venous Thromboembolism Diagnosis and Management(6), Long-Term Effects of COVID-19(5), Atrial Fibrillation Management and Outcomes(2), Heart Failure Treatment and Management(2)

Publications17 total

Efficacy and safety profile of empaglifozin following acute myocardial infarction: A meta-analysis of randomized controlled trials
Atherosclerosis·2025Open Access
Exploring the potential of handgrip strength as a prognostic marker in acute decompensated heart failure with reduced ejection fraction: a cross-sectional study
Scientific Reports·2025Open Access
A Multifaceted Intervention to Mitigate the Adverse Cardiovascular Effects of Air Pollution: A Feasibility Randomized Controlled Trial
Journal of Cardiovascular Pharmacology·2025
Invasive versus conservative strategies for non-ST-elevation acute coronary syndrome in the elderly: an updated systematic review and meta-analysis of randomized controlled trials
BMC Cardiovascular Disorders·2025· 4 citedOpen Access
Comparing myocardial injury patterns and outcomes in cardiac magnetic resonance imaging between COVID-19- and non-COVID-19-related myocarditis
Polish Journal of Radiology·2025Open Access
Clinical and Computational Analysis of Left Subclavian Artery Coverage on High-Risk Blunt Thoracic Aortic Injury
SSRN Electronic Journal·2025Open Access
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials
EuroIntervention·2024· 19 citedOpen Access
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
Frontiers in Medicine·2024· 89 citedOpen Access
Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial
Arteriosclerosis Thrombosis and Vascular Biology·2023
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Thrombosis and Haemostasis·2023· 8 citedOpen Access
RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial
International Journal of Cardiology·2022· 16 cited
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Thrombosis and Haemostasis·2021· 78 citedOpen Access
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
JAMA·2021· 644 citedOpen Access
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Journal of the American College of Cardiology·2021· 177 citedOpen Access
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
2021· 10 citedOpen Access
Impact of registry implementation on the management and survival of patients with pulmonary embolism
Research in Cardiovascular Medicine·2021· 2 citedOpen Access
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Thrombosis Research·2020· 84 citedOpen Access

Frequent Co-authors

Parham Sadeghipour(16), Azita H. Talasaz(9), Harlan M. Krumholz(9), Behnood Bikdeli(9), Majid Maleki(8), Gregory Piazza(8), Gregory Y.H. Lip(8), Hooman Bakhshandeh(7), David Jiménez(7), Sahil A. Parikh(7), Manuel Monréal(7), Ajay J. Kirtane(7), Samuel Z. Goldhaber(7), Bahram Mohebbi(6), Hessam Kakavand(6), Benjamín Van Tassell(6), Gregg W. Stone(6), Farid Rashidi(5), Babak Sharif-Kashani(5), Mohammad Taghi Beigmohammadi(5)